TeraView’s 6G Technology Receives Investment from UK - IDEX Health & ScienceIDEX Health & Science


    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    TeraView’s 6G Technology Receives Investment from UK

    Article obtained from Photonics RSS Feed.

    Teraview, a developer of terahertz light-based solutions, received £191 million in development funding from the Sustainable Innovation Fund with Innovate UK, the United Kingdom’s innovation agency. The funding is targeted at TeraView’s technology for next-generation 6G network applications using terahertz frequencies. The technology may additionally deliver other functions, such as more precise positional information and developments in imaging in support of applications, including virtual reality. Teraview develops terahertz test measurement solutions for numerous applications, including the evaluation of 6G networks.

    Jan, 15 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.